Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03696602
Other study ID # enf4327
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 1, 2006
Est. completion date September 30, 2016

Study information

Verified date September 2018
Source Central Hospital, Nancy, France
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Deep inhalation (DI) dilates normal airway precontracted with methacholine. The fact that this effect is diminished or absent in asthma could be explained by the presence of bronchial inflammation. The hypothesis tested was that DI induces more relaxation in methacholine induced bronchoconstriction—solely determined by the smooth muscle contraction—than in exercise induced bronchoconstriction, which is contributed to by both smooth muscle contraction and airway wall inflammation.


Description:

Children were referred to the lung function department by their pediatric pulmonologist. Asthma was defined by a complaint of wheezing, cough, dyspnoea or chest tightness at rest or on exercising and a positive response to methacholine or exercise challenge.

The response to exercise was considered positive when Forced Expiratory Volume in 1 s (FEV1) decreased at least 8% from Baseline.

The response to methacholine was considered positive when FEV1 decreased at least 20% or Rrs increased at least 50% from baseline, at or below a cumulated dose of 1,200 μg.

Bronchodilator medications were discontinued at least 12 hours prior to the testing and provocation allowed when the child had been free of respiratory symptoms for at least 2 weeks and baseline FEV1 was larger than 70% pred. Exercise and methacholine groups were matched for age, height, baseline FEV1 z-score, a moderate level of airway response to challenge and DI amplitude ranging 40-60% of the predicted Forced Vital Capacity (FVC). Written informed consent was obtained from the children and their parents for the procedures. Procedures for spirometry, exhaled fraction of NO (FENO), GrsDI (Respiratory conductance response to a deep inhalation) and challenges have been described previously. Acceptable GrsDI's were analyzed at a 10-20% FEV1 decrease from baseline. Statistics were performed using Mann-Whitney, Chi square tests and multiple regression as required. Data are median and interquartile range.


Recruitment information / eligibility

Status Completed
Enrollment 78
Est. completion date September 30, 2016
Est. primary completion date June 30, 2016
Accepts healthy volunteers No
Gender All
Age group 6 Years to 14 Years
Eligibility Inclusion Criteria:

- Children referred to the lung function department by their pediatric pulmonologist.

- Asthma defined by a complaint of wheezing, cough and dyspnoea.

- Positive response to methacholine or exercise challenge.

- Bronchodilator medications discontinued at least 12 h prior to the testing

- Provocation allowed when the child had been free of respiratory symptoms for at least 2 weeks and baseline FEV1 larger than 70% pred.

Exclusion Criteria:

- Other respiratory diseases than asthma

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
bronchial provocation test


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Central Hospital, Nancy, France

Outcome

Type Measure Description Time frame Safety issue
Primary Grs change between before deep breath and after deep breath in exercise and metacholine groups GrsDI represents Grs measured after deep breath reported to Grs before deep breath (bronchial provocation test) through study completion, an average of 1 hour
See also
  Status Clinical Trial Phase
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT05066841 - Chinese Herbal Medicine Formula Combined With Inhaled Corticosteroids for the Treatment of Mild to Persistent Asthma in Children N/A
Not yet recruiting NCT05105386 - The Impact of Synergies of Indoor Air Pollutants on Childhood Health and Wellbeing
Completed NCT01450774 - Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Assessed by Knemometry and Urinary Cortisol Measurements in Asthmatic Children Phase 3
Completed NCT05390554 - Using Buteyko Breathing Technique to Control Asthma in School-Age Children N/A
Active, not recruiting NCT04089085 - STRONGer Together: A Small Group Intervention for Children With Asthma and Anxiety/Depression N/A
Completed NCT03304067 - Asthma Control Study N/A
Completed NCT02451709 - STudy of Asthma Adherence Reminders N/A
Withdrawn NCT01451944 - Effect of Home Health Case Management on Asthma Morbidity N/A
Completed NCT00204828 - T Regulatory and Childhood Asthma
Completed NCT01472471 - Urinary 8-isoprostane is Elevated in Acute Childhood Asthma N/A
Completed NCT03278561 - General Risk Factors and Inflammatory Determinants in Older Patients With Asthma
Completed NCT02702687 - Childhood Asthma Perception Study N/A
Completed NCT03514485 - West Philadelphia Controls Asthma N/A
Not yet recruiting NCT02678949 - Changes in the Lung Clearance Index in Pediatric Patients With Asthma N/A
Completed NCT02404103 - Flunisolide HFA in Children With Small Airway Disease N/A
Completed NCT02341573 - Experienced Chinese Herbal Formulas on Pediatric Asthma N/A
Completed NCT03481673 - COPE for Children With Asthma: Intervention for Children With Asthma N/A
Recruiting NCT04250779 - Evaluating Efficacy of Smart Device in Assisting With Inhaler Technique and Adherence Early Phase 1
Completed NCT02405962 - Training Parents by Acceptance and Commitment Therapy for Managing Childhood Asthma Care N/A